T1	Participants 147 189	large population of hypertensive patients.
T2	Participants 301 387	cardiovascular target organ damage and metabolic profile in 520 hypertensive patients.
T3	Participants 837 845	patients
T4	Participants 1259 1280	hypertensive patients
